Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-28

Clinical Trial Update: Cellulose Sulfate and HIV Transmission Among Women [Phase 3]

View source ↗

Summary

Phase 3 trial of cellulose sulfate for HIV prevention in women was terminated early due to futility and safety concerns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cellulose sulfate (cellulose sulfate)

Snippet

Sponsor: CONRAD | Conditions: HIV Infection | Phase 3 | Status: TERMINATED